The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
-
Page 37
(2010/02/10)
More Articles about upstream products of 823189-15-7